DNA ligand designed to antagonize EBNA1 represses Epstein–Barr virus-induced immortalization
Version of Record online: 30 SEP 2011
© 2011 Japanese Cancer Association
Volume 102, Issue 12, pages 2221–2230, December 2011
How to Cite
Yasuda, A., Noguchi, K., Minoshima, M., Kashiwazaki, G., Kanda, T., Katayama, K., Mitsuhashi, J., Bando, T., Sugiyama, H. and Sugimoto, Y. (2011), DNA ligand designed to antagonize EBNA1 represses Epstein–Barr virus-induced immortalization. Cancer Science, 102: 2221–2230. doi: 10.1111/j.1349-7006.2011.02098.x
- Issue online: 20 NOV 2011
- Version of Record online: 30 SEP 2011
- Accepted manuscript online: 12 SEP 2011 03:58PM EST
- (Received July 31, 2011/Revised September 4, 2011/Accepted September 5, 2011/Accepted manuscript online September 12, 2011)
Fig. S1. Structure of the EBNA1–DNA binding domain.
Fig. S2. DSE-3 did not inhibit NF-κB.
Fig. S3. Possible binding of DSE-3 to sites 1–4.
Fig. S4. Possible polyamide targets at the DS.
Fig. S5. Flowcytometer analysis of DSE-3-treated cells.
Fig. S6. EBNA1-bound sequences at the DS and the FR.
Data S1. Supplementary materials and methods.
Data S2. Supplementary figure legends.
|CAS_2098_sm_DataS1.doc||43K||Supporting info item|
|CAS_2098_sm_DataS2.doc||38K||Supporting info item|
|CAS_2098_sm_fS1.tif||825K||Supporting info item|
|CAS_2098_sm_fS2.tif||379K||Supporting info item|
|CAS_2098_sm_fS3.tif||14743K||Supporting info item|
|CAS_2098_sm_fS4.tif||12745K||Supporting info item|
|CAS_2098_sm_fS5.tif||7697K||Supporting info item|
|CAS_2098_sm_fS6.tif||13804K||Supporting info item|
Please note: Wiley Blackwell is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.